Lung Therapeutics

Lung Therapeutics is a clinical-stage pharmaceutical company developing innovative therapies for fibrosis, lung injury, and related conditions. We have a highly promising pipeline, featuring two leading programs: LTI-01 and LTI-03. Our goal is to provide better treatment options for patients with life-threatening lung diseases.